Skip to content

BCRXBIOCRYST PHARMACEUTICALS INC

CUSIP 09058V103 · common stock

4 tracked investors held BIOCRYST PHARMACEUTICALS INC (BCRX) at the end of Q3 2026, worth $113.9M in total. The largest holder was Perceptive Advisors, with 1.5% of its portfolio. RA Capital Management sold out of its position this quarter.

Holders · Q3 2026
4
New holders
0
Value held
$113.9M
Quarter-end price (est.)
$8.33

Investors holding BCRX · Q3 2026

InvestorWeightSharesValueChange
Perceptive Advisors
Perceptive Advisors LLC
1.49%10,301,888$85.8MREDUCE-0.1%
Ken Fisher
Fisher Asset Management, LLC
0.01%2,448,598$20.4MREDUCE-6.0%
Joel Greenblatt
Gotham Asset Management, LLC
0.01%471,090$3.9MADD+201.2%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.16%447,105$3.7MADD+236.2%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
RA Capital Management1.38%15,827,186$158.3MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026401$113.9M$8.33
Q2 2026500$290.3M$10.00
Q1 2026501$251.4M$9.52
Q4 2025600$191.4M$7.80